Experiment summary for ENCSR764JRB
doi:10.17989/ENCSR764JRB
Summary
- Status
- released
- Assay
- Mint-ChIP-seq (Control Mint-ChIP-seq)
- Control type
- input library
- Biosample summary
- Homo sapiens activated naive CD4-positive, alpha-beta T cell male adult (43 years) treated with 10 ng/mL Interleukin-2 for 5 days, anti-CD3 and anti-CD28 coated beads for 7 days
- Biosample Type
- primary cell
- Replication type
- unreplicated
- Description
- Control Mint-ChIP-seq of activated CD4-positive, alpha-beta T cell male adult (43 years) treated with 10 ng
- Treatments
- 10 ng/mL Interleukin-2 (UniProtKB:P60568) for 5 days, anti-CD3 and anti-CD28 coated beads for 7 days
- Nucleic acid type
- DNA
- Platform
- Illumina NextSeq 500
Attribution
ENCODE4 project
- Lab
- Bradley Bernstein, Broad
- Award
- UM1HG009390 (Bradley Bernstein, Broad)
- Project
- ENCODE
- External resources
- Aliases
- bradley-bernstein:Project Element 4935
- Date released
- April 28, 2021
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 1 | 1 | Homo sapiens male adult (43 years) activated naive CD4-positive, alpha-beta T primary cell treated with 10 ng/mL Interleukin-2 for 5 days, anti-CD3 and anti-CD28 coated beads for 7 days | ENCBS377CVF | ENCLB770CRW |
| 1 | 2 | Homo sapiens male adult (43 years) activated naive CD4-positive, alpha-beta T primary cell treated with 10 ng/mL Interleukin-2 for 5 days, anti-CD3 and anti-CD28 coated beads for 7 days | ENCBS377CVF | ENCLB242KIC |